Clinical Trials Logo

Ischemic Stroke clinical trials

View clinical trials related to Ischemic Stroke.

Filter by:

NCT ID: NCT03887143 Completed - Clinical trials for Arterial Ischemic Stroke

National Retrospective Study Of Recanalization Treatments In Pediatric Arterial Ischemic Stroke

KID-CLOT
Start date: April 4, 2019
Phase:
Study type: Observational

The purpose of this study is to evaluate recanalization treatments use, safety and efficacy at the acute phase of arterial ischemic stroke in pediatric patients

NCT ID: NCT03884530 Completed - Ischemic Stroke Clinical Trials

Ticagrelol Versus Aspirin in Ischemic Stroke

Start date: May 1, 2019
Phase: Phase 3
Study type: Interventional

There is a debate whether ticagrelor is superior to aspirin in treating patients with ischemic stroke or not, most of the studies examine the effect of both drugs within 24 hours of acute stroke some find that there is no difference between ticagrelor and aspirin, others find that ticagrelor is superior to aspirin. At this study the investigators aim at evaluating the role of loading ticagrelor received within 9 hours of acute ischemic stroke in improving neurological outcome of stroke. And evaluating the risk of hemorrhagic and non- hemorrhagic complications associated with the use of ticagrelor180 ml oral loading dose within 9 hours acute ischemic stroke

NCT ID: NCT03876457 Completed - Clinical trials for Acute Ischemic Stroke

SELECT2: A Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke

SELECT2
Start date: October 11, 2019
Phase: N/A
Study type: Interventional

SELECT 2 evaluates the efficacy and safety of endovascular thrombectomy compared to medical management alone in acute ischemic stroke patients due to a large vessel occlusion in the distal ICA and MCA M1 who have large core on either CT (ASPECTS: 3-5) or advanced perfusion imaging ([rCBF<30%] on CTP or [ADC<620] on MRI: ≥50cc) or both and are treated within 0-24 hours from last known well.

NCT ID: NCT03871517 Completed - Ischemic Stroke Clinical Trials

INdobufen Versus aSpirin in acUte Ischemic stRokE,INSURE

Start date: June 3, 2019
Phase: Phase 4
Study type: Interventional

China has the largest burden of cerebrovascular disease in the world. About 60% to 80% of which are ischemic stroke. In recent years, stroke has replaced heart disease and tumor diseases as the first cause of death and disability in adult population. The primary purpose of this study is to evaluate the efficacy of indobufen treatment in reducing the risk of a 3-month new stroke (any type of stroke, including ischemic stroke and hemorrhagic stroke) for patients with moderate/severe ischemic stroke is not inferior to aspirin therapy.

NCT ID: NCT03868007 Completed - Clinical trials for Acute Coronary Syndrome

Protective Effects of RIC in Elderly With Acute Ischemic Stroke Complicating Acute Coronary Syndrome

RIC-ACS
Start date: March 10, 2019
Phase: N/A
Study type: Interventional

Remote ischemic conditioning (RIC) is a noninvasive strategy in which one or more cycles of brief and transient limb ischemia confers protection against prolonged and severe ischemia in distant organs.This study aimed to investigate whether RIC is safe and effective in patients with AIS complicating ACS

NCT ID: NCT03861494 Completed - Ischemic Stroke Clinical Trials

REcurrent Stroke Prevention Through Personalized Education by Clinical Trainers (RESPPECT Trial)

RESPPECT
Start date: May 6, 2019
Phase: N/A
Study type: Interventional

This a single blind randomized control study comparing standard of care for nursing hospital discharge education versus same with an additional experimental enhanced educational intervention. It is planned that 300 patients will be enrolled in the study. There are two initial groups: the enhanced stroke education vs usual stroke education.

NCT ID: NCT03845491 Completed - Ischemic Stroke Clinical Trials

ASSIST Registry Studying Various Operator Techniques

Start date: January 23, 2019
Phase:
Study type: Observational [Patient Registry]

The purpose of this Registry is to assess the procedural success and clinical outcomes associated with various operator techniques for mechanical thrombectomy in large vessel occlusions (LVO).

NCT ID: NCT03833375 Completed - Clinical trials for Traumatic Brain Injury

Shared Decision Making to Improve Goals-of-Care Decisions for Families of Severe Acute Brain Injury Patients

Start date: February 11, 2018
Phase: N/A
Study type: Interventional

Severe acute brain injury (SABI), including large artery acute ischemic stroke, intracerebral hemorrhage, and severe traumatic brain injury continue to be the leading cause of death and disability in adults in the U.S. Due to concerns for a poor long-term quality of life, withdrawal of mechanical ventilation and supportive medical care with transition to comfort care is the most common cause of death in SABI, but occurs at a highly variable rate (for example in Traumatic Brain Injury (TBI) 45-89%). Decision aids (DAs) are shared decision-making tools which have been successfully implemented and validated for many other diseases to assist difficult decision making. The investigators have developed a pilot DA for goals-of-care decisions for surrogates of SABI patients. This was developed through qualitative research using semi-structured interviews in surrogate decision makers of TBI patients and physicians. The investigators now propose to pilot-test a DA for surrogates of SABI patients in a feasibility trial.

NCT ID: NCT03827720 Completed - Ischemic Stroke Clinical Trials

Early Feasibility Study of the SENSE Device

Start date: June 6, 2019
Phase: N/A
Study type: Interventional

A single site, study of the SENSE device in up to 20 study subjects, (five healthy controls and five each with ICH, AIS with LVO and AIS without LVO) in whom SENSE can be applied within 24 hours of stroke symptom onset.

NCT ID: NCT03825419 Completed - Clinical trials for Acute Ischemic Stroke

Detection of Muscle Loss in Acute Stroke Patients Who Need Enteral Nutrition (MASS)

MASS
Start date: January 23, 2019
Phase:
Study type: Observational

The degree of muscle loss over the course of inpatient stay will be evaluated in patients with a diagnosis of acute ischemic stroke admitted to Neurocritical Care Units and necessitating enteral nutrition.